Literature DB >> 15180945

Destructive cycles: the role of genomic instability and adaptation in carcinogenesis.

Brandt L Schneider1, Molly Kulesz-Martin.   

Abstract

Classical theories of carcinogenesis postulate that the accumulation of several somatic mutations is responsible for oncogenesis. However, these models do not explain how non-mutagenic carcinogens cause cancer. In addition, known mutation rates appear to be insufficient to account for observed cancer rates. Moreover, the current theory doesn't easily account for the long latencies observed in human cancers. Proponents of an aneuploidy-driven theory of carcinogenesis suggest that genomic instability has a causative role in carcinogenesis. In support of this theory, pre-neoplastic cells frequently display genomic instability while normal cells do not. Data obtained from a variety of model organisms have revealed that disruption of the cell cycle controls required for homeostasis results in the acquisition of genomic instability. Subsequently, this genomic instability becomes self-propagating via 'destructive cycles' and provides a medium for cellular selection and adaptation. Genomic instability allows numerous genetic and epigenetic alterations to accumulate during carcinogenesis without markedly changing phenotype until they are qualitatively or quantitatively sufficient to be selectively advantageous in the tumor microenvironment. Observations of adaptation in tumor cell populations and application of chaos theory may help elucidate the mechanism that drives the enormous genetic heterogeneity observed in tumors and provide insights into the development of new therapeutic cancer interventions and treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180945     DOI: 10.1093/carcin/bgh204

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.

Authors:  Yuzhe Yang; Douglas Yee
Journal:  Cancer Res       Date:  2014-03-31       Impact factor: 12.701

2.  From aneuploidy to cancer: the evolution of a new species?

Authors:  Samuel Knauss; Andreas Klein
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

3.  Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.

Authors:  Steven B Chinn; Owen A Darr; John H Owen; Emily Bellile; Jonathan B McHugh; Matthew E Spector; Silvana M Papagerakis; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E P Prince
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

4.  Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.

Authors:  Katja Linher-Melville; Sina Haftchenary; Patrick Gunning; Gurmit Singh
Journal:  Mol Cell Biochem       Date:  2015-04-21       Impact factor: 3.396

Review 5.  Genome-based versus gene-based theory of cancer: possible implications for clinical practice.

Authors:  Natasa Todorovic-Rakovic
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

6.  Natural history of intraductal papillary mucinous neoplasia: How much do we really know?

Authors:  Chad G Ball; Thomas J Howard
Journal:  World J Gastrointest Surg       Date:  2010-10-27

7.  β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer (MCF-7) cells.

Authors:  G Sowmya Shree; K Yogendra Prasad; H S Arpitha; U R Deepika; K Nawneet Kumar; Priya Mondal; P Ganesan
Journal:  Mol Cell Biochem       Date:  2017-05-26       Impact factor: 3.396

8.  Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype.

Authors:  Antonella De Luca; Fabio Sanna; Michele Sallese; Carmen Ruggiero; Mauro Grossi; Paolo Sacchetta; Cosmo Rossi; Vincenzo De Laurenzi; Carmine Di Ilio; Bartolo Favaloro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 9.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Authors:  Dunyaporn Trachootham; Jerome Alexandre; Peng Huang
Journal:  Nat Rev Drug Discov       Date:  2009-05-29       Impact factor: 84.694

10.  Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.

Authors:  Jana Jeschke; Heather M O'Hagan; Wei Zhang; Rajita Vatapalli; Marilia Freitas Calmon; Ludmila Danilova; Claudia Nelkenbrecher; Leander Van Neste; Ingrid T G W Bijsmans; Manon Van Engeland; Edward Gabrielson; Kornel E Schuebel; Andreas Winterpacht; Stephen B Baylin; James G Herman; Nita Ahuja
Journal:  Clin Cancer Res       Date:  2013-04-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.